115 related articles for article (PubMed ID: 23553339)
1. RNA interference in the treatment of colon cancer.
Prados J; Melguizo C; Roldan H; Alvarez PJ; Ortiz R; Arias JL; Aranega A
BioDrugs; 2013 Aug; 27(4):317-27. PubMed ID: 23553339
[TBL] [Abstract][Full Text] [Related]
2. RNA interference in cancer.
Gartel AL; Kandel ES
Biomol Eng; 2006 Mar; 23(1):17-34. PubMed ID: 16466964
[TBL] [Abstract][Full Text] [Related]
3. RNA interference for the treatment of cancer.
Putral LN; Gu W; McMillan NA
Drug News Perspect; 2006; 19(6):317-24. PubMed ID: 16971967
[TBL] [Abstract][Full Text] [Related]
4. Analysis of gene expression profile in colon cancer using the Cancer Genome Anatomy Project and RNA interference.
Huang ZG; Ran ZH; Lu W; Xiao SD
Chin J Dig Dis; 2006; 7(2):97-102. PubMed ID: 16643337
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
[TBL] [Abstract][Full Text] [Related]
6. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
7. Profile of protein expression of the colon cancer cell line SW480 with survivin/shRNA.
Wang X; Fu Z; Zhao Y; Wu X; Shen W
Eur J Cancer Prev; 2011 May; 20(3):190-8. PubMed ID: 21200325
[TBL] [Abstract][Full Text] [Related]
8. Specific knockdown of PPARδ gene in colon cancer cells by lentivirus-mediated RNA interfering.
Yang L; Zhou ZG; Sun XF
Methods Mol Biol; 2013; 952():67-86. PubMed ID: 23100225
[TBL] [Abstract][Full Text] [Related]
9. [RNA interference (RNAi) and its therapeutic potential in cancer].
Vázquez-Vega S; Contreras-Paredes A; Lizano-Soberón M; Amador-Molina A; García-Carrancá A; Sánchez-Suárez LP; Benítez-Bribiesca L
Rev Invest Clin; 2010; 62(1):81-90. PubMed ID: 20415062
[TBL] [Abstract][Full Text] [Related]
10. RNAi technology: a revolutionary tool for the colorectal cancer therapeutics.
Lv W; Zhang C; Hao J
World J Gastroenterol; 2006 Aug; 12(29):4636-9. PubMed ID: 16937431
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 knockdown by RNA interference in colon cancer.
Charames GS; Bapat B
Int J Oncol; 2006 Feb; 28(2):543-9. PubMed ID: 16391811
[TBL] [Abstract][Full Text] [Related]
12. Potential use of RNA interference in cancer therapy.
Phalon C; Rao DD; Nemunaitis J
Expert Rev Mol Med; 2010 Aug; 12():e26. PubMed ID: 20716384
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy targeting Raf-1 and MEK causes apoptosis of HCT116 colon cancer cells.
Subramanian RR; Yamakawa A
Int J Oncol; 2012 Nov; 41(5):1855-62. PubMed ID: 22922669
[TBL] [Abstract][Full Text] [Related]
14. Emerging nanodelivery strategies of RNAi molecules for colon cancer therapy: preclinical developments.
Binkhathlan Z; Alshamsan A
Ther Deliv; 2012 Sep; 3(9):1117-30. PubMed ID: 23035595
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo gene silencing by TransKingdom RNAi (tkRNAi).
Xiang S; Keates AC; Fruehauf J; Yang Y; Guo H; Nguyen T; Li CJ
Methods Mol Biol; 2009; 487():147-60. PubMed ID: 19301646
[TBL] [Abstract][Full Text] [Related]
16. [Combinatorial RNAi and its application in cancer gene therapy].
Fei LN; Wang QZ; Xu RA
Yao Xue Xue Bao; 2012 May; 47(5):573-9. PubMed ID: 22811998
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer stem cells: from the crypt to the clinic.
Zeuner A; Todaro M; Stassi G; De Maria R
Cell Stem Cell; 2014 Dec; 15(6):692-705. PubMed ID: 25479747
[TBL] [Abstract][Full Text] [Related]
18. SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis.
Tsuchiya N; Ochiai M; Nakashima K; Ubagai T; Sugimura T; Nakagama H
Cancer Res; 2007 Oct; 67(19):9568-76. PubMed ID: 17909068
[TBL] [Abstract][Full Text] [Related]
19. RNA interference--a silent but an efficient therapeutic tool.
Ramachandran PV; Ignacimuthu S
Appl Biochem Biotechnol; 2013 Mar; 169(6):1774-89. PubMed ID: 23340870
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral vector-mediated RNAi and its use for cancer research.
Sumimoto H; Kawakami Y
Future Oncol; 2007 Dec; 3(6):655-64. PubMed ID: 18041918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
